多种类型的抗体诱导有针对性的调控下调的编程死亡链接1
Seth D Ludwig1, Bunyarit Meksiriporn2, Jiacheng Tan3
1Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.
Cell chemical biology
|March 28, 2024
概括
新的抗体融合蛋白准分子贩运,以阻止PD-L1和PD-1等免疫检查点. 这种双重机制增强T细胞激活,并减少瘤PD-L1,为癌症免疫治疗提供了一种新的方法.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 编程死亡配体1 (PD-L1) 通过其受体PD-1抑制T细胞的反应.
- 免疫检查点蛋白在瘤中的过度表达需要改进治疗策略.
- 目前阻断PD-L1/PD-1相互作用的抗体疗法显示反应率有限.
研究的目的:
- 开发针对免疫检查点路径的新型抗体融合蛋白.
- 调查涉及分子贩运的独特作用机制.
- 通过改善T细胞激活来提高癌症免疫疗法的疗效.
主要方法:
- 工程设计的多种类型的抗体,可以激活多个PD-L1表位.
- 研究了PD-L1.1的表位和拓依赖的聚类,内部化和退化.
- 在小鼠瘤模型中评估免疫细胞激活和PD-L1可用性.
主要成果:
- 多种类型的抗体诱导了PD-L1的快速聚类,内化和降解.
- 结合连接体阻断和受体下调,增强了T细胞激活的耐久性.
- 在小鼠瘤中观察到PD-L1可用性显著降低.
结论:
- 多种类型的抗体提供了一种新的机制,通过分子贩运来阻止免疫检查点.
- 这种方法增强了免疫细胞的激活,并减少了瘤PD-L1.
- 这些发现为潜在的治疗操纵提供了对免疫检查点蛋白贩运的机制性见解.
更多相关视频
06:12Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
1.9K
08:12Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Published on: August 11, 2014
9.8K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Extrinsic Apoptotic Pathway
6.4K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K
Cytotoxic T Cells-mediated Immune Response
907
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
907
